Clear Reflection Complexion Acne Treatment Serum

Manufacturer
Renu Laboratories, Inc.
Effective date
2023-10-30
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:58:30

Label at a glance#

ProductClear Reflection Complexion Acne Treatment Serum
Active ingredientSALICYLIC ACID
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

2 percent Salicylic Acid

WARNINGS SECTION

For external use only.

OTC - DO NOT USE SECTION

Do not use this medication if you have very sensitive skin or if you are sensitive to salicylic acid.

OTC - WHEN USING SECTION

Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one medication at a time.

Avoid contact with the eyes

If contact occurs, rinse thoroughly with water

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions

In the morning, after cleansing face, apply serum evenly and make sure all problem areas are treated. Mild tingling may occur. If bothersome dryness occurs, reduce application to once every other day.

INACTIVE INGREDIENT SECTION

Cyclopentasiloxane, Dimethiconol, Isopropyl Alcohol, Octyldodecanol, Helianthus Annuus (Sunflower) Seed Oil, Dimethicone, Dihydroeugenol, Isoeugenyl, Cinnamal, Ethyl Vanilla.

OTC - PURPOSE SECTION

Acne Treatment

INDICATIONS & USAGE SECTION

Recommended use is in the morning after cleansing and before applying any makeup.

OTC - QUESTIONS SECTION

Call Customer Service at 1 800 990 6552 or contact customerservice@dermamedics.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CLEAR REFLECTION SERUMCLEAR REFLECTION SERUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
346298salicylic acid 2 % Topical GelPSN1
346298salicylic acid 0.02 MG/MG Topical GelSCD1
346298salicylic acid 2 % Topical GelSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
76348-685-022025-01-30C16284748780-12cef2736-5d04-d83d-e063-dadaa90ab31fClear Reflection Complexion Acne Treatment Serum

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76348-685-02Clear Reflection Complexion Acne Treatment Serum52 mL in 1 BOTTLE, PUMPGEL521

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76348-685CLEAR REFLECTION COMPLEXION ACNE TREATMENT SERUM (SALICYLIC ACID 2%) GEL [RENU LABORATORIES, INC.]11 package rows20231101_08f56c9e-921c-4e48-e063-6294a90a56db.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76348-68576348-685-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
08f56c9e-921d-4e48-e063-6294a90a56db08f56c9e-921c-4e48-e063-6294a90a56db2023-10-30WarningsExact identifier
spl id: 08f56c9e-921d-4e48-e063-6294a90a56db
spl set id: 08f56c9e-921c-4e48-e063-6294a90a56db

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.